Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 14/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SLC5A1 | P13866 | 8/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | SLC5A11 | Q8WWX8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16600692 | 0.94 | SLC5A2 (0.47) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| SCHEMBL27788342 | 0.93 | SLC5A2 (0.46) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| SCHEMBL27788263 | 0.92 | SLC5A2 (0.44) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| Chlorolithium SCHEMBL29084912 | 0.90 | SLC5A2 (0.42) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| Chlorolithium SCHEMBL29084967 | 0.90 | SLC5A2 (0.42) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| SCHEMBL29041345 | 0.80 | SLC5A2 (0.35) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| SCHEMBL27820545 | 0.76 | SLC5A2 (0.35) | SLC5A2SLC5A1 | |
| SCHEMBL16601002 | 0.74 | SLC5A2 (0.45) | SLC5A2SLC5A1KDM4ESMN1; SMN2 | |
| SCHEMBL3622807 | 0.73 | MEN1 (0.66) | SLC5A2MEN1KMT2ASLC5A1KDM4E | |
| SCHEMBL7785329 | 0.72 | NQO1 (0.56) | KDM4EHPGDSMN1; SMN2DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116789716-A | Preparation method of dapagliflozin and Ai Tuoge gliflozin intermediate | 南京科默生物医药有限公司 | 2023-09-22 | — | — | CN | disclosed |